Lexicon Pharmaceuticals
  • Home
  • Contact Us
  • Site Map
  • About Us
    • About Us Home
    • Management Team
    • Board of Directors
    • Development Team
    • Locations
    • Contact Us
    • History
  • Pipeline
    • Drug Pipeline Home
    • Our Goal
    • Therapeutic Areas
    • Drug Development Team
    • Clinical Trials
    • Publications
  • Discovery
    • Discovery Home
    • Discovery Process
    • Technology
    • Genome5000
    • Medicinal Chemistry
    • Patents
    • Academic Access
    • Technology Licensing
    • Scientific Publications
  • Alliances
    • Alliances Home
    • Current Alliances
    • Technology Licensing
  • Careers
    • Careers Home
    • Opportunities
    • Our Culture
    • Benefits
    • Community Involvement
    • The Woodlands
    • Princeton
    • Awards and Recognition
  • News
    • News Home
    • Media Inquiries
  • Investors
    • Investors Home
    • Media
    • Events
    • Stock Quote
    • SEC Filings
    • Annual Reports
    • Corporate Governance
    • Request Information
Lexicon Banner
  • News Home
  • Media Inquiries
Subscribe
Press Releases
Filter     Display # 
12/01/2008 Lexicon Files Investigational New Drug Application for LX4211 as a Potential Treatment for Diabetes
11/24/2008 Lexicon Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
11/13/2008 Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Successfully Completes Phase 1 Clinical Trials
10/30/2008 Lexicon Pharmaceuticals Reports 2008 Third Quarter Financial Results
10/25/2008 Lexicon Presents Phase 1 Clinical Trial Results for LX2931 at American College of Rheumatology Annual Meeting
08/13/2008 Lexicon Pharmaceuticals Identifies New Drug Candidate for Glaucoma
07/29/2008 Lexicon Pharmaceuticals' Drug Candidate for Irritable Bowel Syndrome Completes Phase 1 Clinical Trial Showing Positive Results
07/29/2008 Lexicon Pharmaceuticals Reports 2008 Second Quarter Financial Results
07/17/2008 Lexicon to Report Second Quarter 2008 Financial Results on July 29, 2008
06/02/2008 Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
 
«StartPrev12345678910NextEnd»
Page 6 of 37
  • About Us
  • Pipeline
  • Discovery
  • Alliances
  • Careers
  • News
  • Investors
  • Terms Of Use

Copyright © 2009, Lexicon Pharmaceuticals, Inc. All rights reserved.